Inventor · disambiguated record
Demetrios Vavvas
Also filed as: VAVVAS DEMETRIOS · VAVVAS DEMETRIOS G
16 granted patents·7 pending applications·23 citations·filing 2011–2021
89Inventor score
Files withMASSACHUSETTS EYE & EAR INFIRMARY13MASSACHUSETTS GEN HOSPITAL4VAVVAS DEMETRIOS2VAVVAS DEMETRIOS G2APELIOTUS TECH INC1
Top patents by PatentIndex Score
23 records- 0191US9492432B2Methods and compositions for preserving photoreceptor and retinal pigment epithelial cellsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Nov 15, 2016·7 cites·15 claims
- 0289US9993517B2Methods and compositions for preserving retinal ganglion cellsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2016·Granted Jun 12, 2018·5 cites·26 claims
- 0387US10149884B2Methods and compositions for preserving photoreceptor and retinal pigment epithelial cellsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2016·Granted Dec 11, 2018·3 cites·11 claims
- 0485US10022419B2Methods for treating spinal cord injuryMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Jul 17, 2018·5 cites·12 claims
- 0570US9724357B2Methods for preserving photoreceptor cell viability following retinal detachmentVAVVAS DEMETRIOS G·Filed 2012·Granted Aug 8, 2017·2 cites·15 claims
- 0668US10143703B2Treating ocular neovascularizationMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Dec 4, 2018·1 cites·12 claims
- 0767US11744817B2High-dose statins for age-related macular degenerationMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2020·Granted Sep 5, 2023·0 cites·21 claims
- 0861US12497437B2Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the treatment of diseasesMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Dec 16, 2025·0 cites·19 claims
- 0960US10258668B2Viral vectors for expressing a modified mullerian inhibiting substance (MIS) proteinMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Apr 16, 2019·0 cites·10 claims
- 1058US2013137642A1Methods and compositions for preserving photoreceptor and retinal pigment epithelial cellsVAVVAS DEMETRIOS·Filed 2011·Application pending·0 cites
- 1157US10799552B2Methods for treating diabetic neurotherapyMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2018·Granted Oct 13, 2020·0 cites·11 claims
- 1256US10639345B2Compositions for preserving photoreceptor cells, retinal pigment epithelial cells, or visual functionMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2018·Granted May 5, 2020·0 cites·12 claims
- 1356US10617735B2Methods and compositions for preserving retinal ganglion cellsMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2018·Granted Apr 14, 2020·0 cites·30 claims
- 1455US9999553B2Materials and methods for oil removalMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Jun 19, 2018·0 cites·19 claims
- 1555US2019351026A1Uses of modified mullerian inhibiting substance (mis) proteins for the treatment of neurodegenerative diseasesMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
- 1655US2014024598A1Methods and compositions for preserving retinal ganglion cellsVAVVAS DEMETRIOS·Filed 2011·Application pending·0 cites
- 1754US11084860B2Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the treatment of diseasesMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Aug 10, 2021·0 cites·14 claims
- 1854US2019201430A1Treating ocular neovascularizationMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2018·Application pending·0 cites
- 1953US2014357570A1Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disordersMASSACHUSETTS EYE & EAR INFIRM·Filed 2012·Application pending·0 cites
- 2051US11331295B2High-dose statins for age-related macular degenerationMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2016·Granted May 17, 2022·0 cites·21 claims
- 2151US10842806B2Methods for treating ocular inflammatory disordersMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2017·Granted Nov 24, 2020·0 cites·15 claims
- 2250US2015005254A1Methods for treating ocular inflammatory disordersVAVVAS DEMETRIOS G·Filed 2012·Application pending·0 cites
- 2343US2020243170A1Functional biomarkers for statin therapy in age-related macular degeneration (amd)APELIOTUS TECH INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →